PharmaShots Weekly Snapshot (March 25-29, 2019)
Published: March 29, 2019 | Tags: Takeda, Signs, Multi- Target Agreement, StrideBio, Develop, Gene Therapies, Neurological Diseases
Published: March 29, 2019 | Tags: Mitsubishi Tanabe Pharma, MTPA, Collaborates, Massachusetts General Hospital, MGH, ALS Biomarker Study
Published: March 29, 2019 | Tags: AstraZeneca, Signs, WW, Collaboration, Daiichi Sankyo, $6.9B
Published: March 29, 2019 | Tags: Gilead, Galapagos, Report, Results, Filgotinib, P-III, FINCH 3 Trial, Moderate-To-Severe, Active, Rheumatoid Arthritis, RA
Published: March 29, 2019 | Tags: Bayer, Signs, Non-Exclusive Licensing Agreement, ProteoNic Biotechnology, 2G UNic Technology
Published: March 28, 2019 | Tags: Johnson N Johnson Vision, Launches, Acuvue Oasys, Transitions Light Intelligent Technology, US
Published: March 28, 2019 | Tags: Apple, Launches, Watch Series 4, ECG App, Irregular Rhythm Notification, Europe, Hong Kong
Published: March 28, 2019 | Tags: Ono Pharmaceutical, Signs, Multi-Year, Collaboration, LifeArc, Cancer Research UK, Develop, Immuno-Therapies, Cancer
?Chugais Risdiplam Receives MHLWs Orphan Drug Designation for Spinal Muscular Atrophy (SMA)
Published: March 28, 2019 | Tags: Chugai, Risdiplam, Receives, MHLW, Orphan Drug Designation, Spinal Muscular Atrophy
Published: March 28, 2019 | Tags: BioLineRx, Reports, Engraftment Data, BL-8040, P-III, GENESIS Trial, Patients, Multiple Myeloma
Published: March 27, 2019 | Tags: Jazz Pharmaceuticals, Reports, Results, ZP-258, P-III, Study, Narcolepsy Patients, Cataplexy, ExcessiveDaytime Sleepiness
Published: March 27, 2019 | Tags: Gilead, Biktarvy, Bictegravir, Emtricitabine,Tenofovir Alafenamide, Receives, Japan, Ministry of Health, Labour and Welfare, Approval, HIV-1 Infection
AstraZenecas Forxiga (dapagliflozin) Receives MHLWs Approval for Type-1 Diabetes (T1D) in Japan
Published: March 27, 2019 | Tags: AstraZeneca, Forxiga, dapagliflozin, Receives, MHLW ,Approval, Type-1 Diabetes, T1D, Adults
Published: March 27, 2019 | Tags: Lilly, Signs, Research Collaboration, ImmuNext, Develop, Commercialize, Novel Therapies, Autoimmune Diseases
Published: March 27, 2019 | Tags: Novartis, Mayzent, siponimod, Receives, FDA, Approval, Patients, Secondary Progressive Multiple Sclerosis, SPMS
Celgene Files NDA for Ozanimod to the US FDA for Relapsing Forms of Multiple Sclerosis (RMS)
Published: March 26, 2019 | Tags: Celgene, Submits, Application, FDA, Ozanimod, Treatment, Relapsing Multiple Sclerosis
Published: March 26, 2019 | Tags: AbbVie, Skyrizi, risankizumab, Receives, FDA, Approval, Treat, Plaque Psoriasis, Generalized Pustular Psoriasis, Erythrodermic Psoriasis, Psoriatic Arthritis, Adults
Almirall Signs a Research Collaboration with HitGen for its DNA-Encoded Technology
Published: March 26, 2019 | Tags: Almirall, Signs, Research Collaboration, HitGen, Technology
Published: March 26, 2019 | Tags: Lupin, YL Biologics, Etanercept, YLB113, Receive, PMDA, Approval, Moderate to Severe, Rheumatoid Arthritis, RA, Juvenile Idiopathic Arthritis, JIA, Japan
Published: March 26, 2019 | Tags: AstraZeneca, Signs, Development, Commercialization, Agreements, Kyowa Hakko Kirin, Fasenra, beralizumab
?Thermo Fischer to Acquire Brammer Bio for $1.7B
Published: March 25, 2019 | Tags: Thermo Fischer; Acquire; Brammer Bio; $1.7B
AstraZenecas Forxiga (dapagliflozin) Receives EUs Approval for Type-1 Diabetes (T1D) in Adults
Published: March 25, 2019 | Tags: AstraZeneca, Forxiga, dapagliflozin, Receives, EU, Approval, Type-1 Diabetes, T1D, Adults
?Eisai Signs a Research Agreement with Cerveau Technologies for its Novel Tau Imaging Agent
Published: March 25, 2019 | Tags: Eisai, Signs, Research Agreement, Cerveau Technologies, Novel Tau Imaging Agent
Published: March 25, 2019 | Tags: Takeda, Collaborates, LegoChem Biosciences, LCB, Develop, Antibody-Drug Conjugates, Immuno-Oncology